Second Generation Tyrosine Kinase Inhibitors and Their Toxicity in Treatment of Patients in Chronic Phase of Chronic Myeloid Leukemia

Background & Aims. Certain experience in the use of new tyrosine kinase inhibitors (TKIs) in treatment of patients with chronic myeloid leukemia has been obtained over the last years. The article summarizes literature data on toxicity obtained in international clinical trials. The aim of the study i...

Celý popis

Podrobná bibliografie

Hlavní autoři:	N. S. Lazorko, Elza Galaktionovna Lomaia, E. G. Romanova, E. I. Sbityakova, E. R. Machyulaitene, P. A. Butylin, A. Yu. Zaritskii
Médium:	Artigo
Jazyk:	Russo
Vydáno:	Practical Medicine Publishing House 2015-07-01
Edice:	Клиническая онкогематология
Témata:	chronic myeloid leukemia tyrosine kinase inhibitors toxicity
On-line přístup:	https://bloodjournal.ru/index.php/coh/article/view/554
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!